122 related articles for article (PubMed ID: 2746861)
1. [Antimicrobial activity of cefteram comparison with other oral antibiotics].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
Jpn J Antibiot; 1989 May; 42(5):1216-32. PubMed ID: 2746861
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial activities of sultamicillin against clinical isolates from upper respiratory tract infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Sep; 41(9):1194-204. PubMed ID: 3266508
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
Yamaguchi K; Ohno A; Takahashi S; Hayashi M; Yamanaka K; Hirakata Y; Mitsuyama J
Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activity of oral Cephems against various clinically isolated strains].
Oshiro T; Fukutomi Y; Takayanagi M; Kusaba K; Nagasawa Z; Aoki Y; Nagayama A
Jpn J Antibiot; 2003 Dec; 56(6):681-90. PubMed ID: 15007876
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):781-93. PubMed ID: 8254898
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1993)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
Jpn J Antibiot; 1996 Feb; 49(2):107-43. PubMed ID: 8721076
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic and clinical studies of cefteram pivoxil granule in the pediatric field].
Motohiro T; Yoshinaga Y; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Tomita S; Sakata Y; Yamashita F
Jpn J Antibiot; 1989 Sep; 42(9):2023-61. PubMed ID: 2810762
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and clinical studies on cefteram pivoxil in the field of pediatrics].
Hayakawa F; Kuno K; Ogawa A; Nakao Y; Takeuchi H; Ando Y; Kito O
Jpn J Antibiot; 1989 Aug; 42(8):1849-59. PubMed ID: 2810748
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
12. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
[TBL] [Abstract][Full Text] [Related]
14. [Antimicrobial activities of cefteram against recently clinically detected and isolated strains from patients with dental infections].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1994 Feb; 47(2):129-42. PubMed ID: 8151907
[TBL] [Abstract][Full Text] [Related]
15. [The antimicrobial activity of cefteram against recently clinically detected and isolated strains].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Suzuki K
Jpn J Antibiot; 1993 Sep; 46(9):801-17. PubMed ID: 8254900
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004].
Matsuzaki K; Watabe E; Furuki A; Kanayama A; Hasegawa M; Sato Y; Kobayashi I
Jpn J Antibiot; 2004 Dec; 57(6):475-80. PubMed ID: 15747585
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
[TBL] [Abstract][Full Text] [Related]
20. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
